Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Name: Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer
Published: 2021
License: Public Domain

Novartis Pharmaceuticals · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

breast-neoplasms

breast neoplasms, alpelisib, fulvestrant, pik3ca mutant advanced breast cancer, randomized cohort, pk cohort, chinese population, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Related documents